Monoclonal antibodies which bind Brucella A lipopolysaccharide (LPS)-specific, M LPS-specific, or cross-reactive epitopes were used as reagents in quantitative dot blot, Western blot (immunoblot), and immunoprecipitation analysis of Brucella whole cells, whole-cell extracts, and purified LPS preparations. This set of monoclonal antibodies detected four unique epitopes on Brucella LPS. The specificity of monoclonal antibodies reactive with Brucella unique (A and M) and common (C and C/Y) LPS epitopes was demonstrated by blot analysis. The serotype specificity of monoclonal antibodies for A LPS of B. abortus 1119.3 or M LPS of Brucella melitensis 16M was confirmed. Type C monoclonal antibodies recognized epitopes on Brucella A and M LPS and did not cross-react with Yersinia enterocolitica 0:9. In Western blots, type C monoclonal antibodies were bound by epitopes on Brucella A and M LPSs ranging in Mrs from 30,000 to 70,000, relative to marker proteins. Type C/Y monoclonal antibodies were cross-reactive with Y. enterocolitica 0:9 and recognized Brucella A LPS epitopes with a restricted Mr ranging only from 40,000 to 50,000, relative to marker proteins. Type C/Y monoclonal antibodies also displayed a more restricted pattern of binding to Brucella M LPS. The monoclonal antibodies were able to detect 5 to 50 pg of a purified A LPS preparation in dot blots. The limits of detection by the monoclonal antibodies of a purified M LPS preparation ranged from 0.05 to 50 pg. Monoclonal antibody analysis of whole-cell preparations also demonstrated quantitative differences in the presence of the respective epitopes. The binding profiles of the monoclonal antibodies to Brucella whole cells varied between acetone-and chloroform-killed organisms as well as between species and strains. The lower limit of detection of any whole-cell preparation by the dot blot technique was 105 CFU. Binding profiles in Western blots and endotoxin activity of immunoprecipitates obtained with these monoclonal antibodies further defined the Brucella LPS antigens. These monoclonal antibodies and the techniques described may be useful in monitoring the antigenic content of Brucella vaccines and diagnostics.
Diagnosis of brucellosis depends mainly on the serological response of the infected host. The serological responses resulting from exposure to smooth Brucella spp. are predominantly against the outer membrane lipopolysaccharide (LPS) and polysaccharide (PS) complexes. Protective, passive, and active immunity have been reported in mice with anti-LPS antibody and with vaccination with LPS complexes (2, 3, 23, 25, 31) . The epitopes associated with this protection have not been adequately defined. The induction of protective immunity through vaccination produces serological reactions to the immunodominant LPS-PS complexes of smooth Brucella spp. which complicate distinguishing between vaccinated and infected hosts.
Brucella LPS-PS complexes consist of the Brucella O chains, native hapten, and polysaccharide B (6, 8, 10) . The existence of this complex has confounded efforts to dissect the epitopes important in Brucella serology (17, 29) . This complex possesses LPS type-specific 0-antigen epitopes (A or M) and recently described epitopes which are common to both LPS types (C and C/Y) (13) . The contributions of native hapten, polysaccharide B, and LPS to these common epitopes have not been established. Better characterization of these LPS-PS complexes is necessary for understanding their role in inducing serological reactions and immunity.
Preparations of supposedly purified Brucella LPS, native hapten, and polysaccharide B antigens possess determinants that can partially cross-absorb LPS-specific polyclonal antibodies (18, 26, 30, 34) . This suggests that Brucella PS antigens copurify with LPS. These PS antigens must, there-fore, be considered when describing the immunochemistry of such preparations. Monitoring the content of Brucella carbohydrate antigens for different types of PS ratios may be important in the preparation of Brucella vaccines and diagnostic reagents (17, 27, 35) .
In this report, immunoblotting techniques, in conjunction with monoclonal antibodies specific for smooth Brucella LPS epitopes, are shown to provide a means with which to further our understanding of these smooth Brucella antigens. These well-characterized monoclonal antibodies are also used to determine the ratios of specific and shared LPS epitopes on smooth Brucella species. Monoclonal antibodies. Monoclonal antibodies were produced as described previously (21) . Briefly, BALB/c mice were immunized with whole B. abortus 2308 or B. melitensis 16M organisms. Spleen cells from immunized mice were fused with X63-Ag8.653 mouse myeloma cells in a modified method of Galfre et al. (19) . The resulting hybridomas were screened for specific monoclonal antibody activity against whole-cell Brucella antigens by ELISA. The production of antibody-containing ascites fluids was accomplished by intraperitoneal injection of trypan blue-primed mice with hybridomas that had been cloned by limiting dilution (16 overnight with rabbit anti-mouse IgG at an optimum relative concentration for precipitation of the mouse IgG. The precipitates were pelleted by centrifugation. The supernatants from the precipitates were removed and saved. The pelleted precipitates were centrifuged and washed three times with ice-cold saline. The precipitates and supernatants were then proteinase K treated to digest the immunoglobulin away from the precipitated LPS. The concentration of LPS in the supernatants and precipitates was determined by the quantitative dot blot assay described below.
MATERIALS AND METHODS
Immunoaffinity chromatography. Monoclonal antibody C-1 was coupled to an Affi-Gel 10 (Bio-Rad Laboratories) slurry in 0.1 M MOPS (morpholinepropanesulfonic acid) buffer, pH 7.5, at 4°C for 4 h. Unbound antibody was washed from the gel matrix with three bed volumes of 0.01 M NaPO4 plus 0.9% NaCl (wt/vol) and followed by three bed volumes ofthe same buffer containing 4 M urea. The column was then equilibrated in buffer without urea (24) .
Purified proteinase K-treated Brucella strain 1119.3 A LPS was allowed to absorb to the column bed at 4°C overnight. Unbound LPS was washed through the column and collected. Antibody-bound LPS was eluted from the column with buffer containing 4 Table 1. PAGE and Western blots. Unlike proteins, the true molecular weights of carbohydrates cannot be determined by their Mrs in PAGE; however, the distribution of oligosaccharides in a sample can be visualized. Compared with those of the E. coli and S. typhimurium standards, whose large 0-chain subunits produce distinct ladder-banding patterns, Brucella A LPS and M LPS 0-chain subunits consisting of one and five monosaccharides, respectively, produce broad smear PAGE distribution patterns (6, 15, 28) .
In Western blots (Fig. 1) , type C monoclonal antibodies were bound by epitopes on purified A and M LPSs ranging from 30,000 to 70,000 relative to marker proteins. The type C/Y monoclonal antibodies recognized A LPS epitopes ranging only from 40,000 to 50,000, relative to marker proteins. The type M and C/Y monoclonal antibodies were also more restricted in binding to M LPS than were the type C monoclonal antibodies.
Western blots of crude, whole-cell extracts also displayed heterogeneous binding patterns (Fig. 2) . The Chloroform-killed Brucella whole cells were proteinase K extracted, and the extracts were run on 10% SDS-PAGE gels and Western blotted. The blotted extracts were reacted with the monoclonal antibodies and detected as described in the text and in the legend to Fig. 1. Lanes 1, 2, 3 , and 4 are silver-stained SDS-PAGE extracts (32) . The numbers represent molecular weight markers (in thousands), which were run but are not shown. Extract from B. melitensis 16M showed a distribution of binding of monoclonal antibodies C-1 and C-2 from below 14,000 to above 97,000, relative to marker proteins (Fig. 2) . The monoclonal antibody M bound B. melitensis 16M extract migrating from 40,000 to 60,000. Binding to the B. melitensis extract by monoclonal antibodies C/Y-1 and C/ Y-2 occurred above 25,000.
Extract from B. abortus biotype 4 weakly bound monoclonal antibodies M, C/Y-1, and C/Y-2. Monoclonal antibodies C-1 and C-2 were bound by epitopes of B. abortus biotype 4 migrating from 30,000 to 50,000. No reactivity with monoclonal antibody A was observed.
Affinity chromatography. Fractions which eluted with urea from the C-1 monoclonal antibody column and contained detectable carbohydrate in PAGE gels were reactive with monoclonal antibodies A, C-1, and C-2 in Western blots. The urea-eluted fractions were not detectable in Western blots by monoclonal antibodies C/Y-1 or C/Y-2 (data not shown). Likewise, when diluted 1:500, the urea-eluted fractions reacted in dot blots with monoclonal antibodies C-1 and C-2 but did not react with C/Y-1 or C/Y-2 (Fig. 3) .
Immunoprecipitation and quantitative dot blot. 
a Purified Brucella 1119.3 LPS precipitated as described in Table 2 and the text.
b Used in the quantitative dot blot.
C Micrograms of LPS in the supernatant detectable after precipitation of 100 p.g of LPS as described in Table 2 . No quantitative difference was observed in the immunoprecipitation of the purified Brucella M LPS preparation. More than 90% of the total M LPS was precipitated by all of the monoclonal antibodies. Likewise, the M LPS precipitates contained 100% of the endotoxin activity prior to precipitation (1.25 EU/0.1 g).
DISCUSSION
This study of smooth Brucella LPS used well-characterized monoclonal antibodies to address questions such as the following. (i) What mixture of LPS and PS molecules do brucellae express? (ii) How can smooth LPS and its complexes with PS be defined? (iii) What are the criteria to establish purity? (iv) What comparisons of the structural relationships of Brucella LPS and PS can be made?
We have previously shown with monoclonal antibodies A and M that Brucella A and M LPSs are distinct, separate antigenic structures with unique and common epitopes (13) . Most serological cross-reactions observed between the LPS types and whole organisms have been attributed to common determinants present on A and M LPS molecules. Monoclonal antibodies C-1 and C-2 detect epitopes common to both A and M LPS types. C/Y-1 and C/Y-2 also detect epitopes common to both Brucella A and M LPS as well as Y. enterocolitica 0:9. Furthermore, the epitopes bound by these monoclonal antibodies are not associated with the oligosaccharides present on rough Brucella spp.
Studies of the A LPS side chain have established that at least part of the serological cross-reactivity of smooth B. abortus 1119.3 and Y. enterocolitica 0:9 is associated with the 1,2-linked N-acylated 4-amino-4,6-dideoxy-Ox-D-mannopyranosyl unit in the 0-chain polysaccharide of their LPSs (9, 10) . The NHs share this 0-chain polymer but lack the lipid A found in LPS (35) . In contrast, purified polyB consists of a family of nonimmunogenic, cyclic 1,2-linked polymers of glucopyranosyl residues (7). LPS complexes of NH and polyB form immunogens that strongly cross-react and also induce serological responses which, in some cases, may be used to indicate whether animals have been either infected or vaccinated (11, 22) .
Biological as well as immunochemical heterogeneity of membrane-bound smooth LPS complex has previously been demonstrated (10, 29, 33, 34) . Brucella LPS profiles in SDS-PAGE have shown heterogeneous patterns from strain to strain, as well as between LPS types (14) . The heterogeneity of purified A LPS observed by nuclear magnetic resonance spectroscopy is attributed to the presence of both E and Z conformations of the N-formyl group (10 Monoclonal antibodies C/Y-1 and C/Y-2 detect a population of molecules in the purified A LPS preparation migrating between 40,000 and 50,000, relative to marker proteins (Fig.  2) . Monoclonal antibody C-2 does not recognize epitopes below 40,000 which monoclonal antibodies A and C-1 bind. Four unique epitopes in Brucella LPS extracts are identified by these monoclonal antibodies. The 0-chain, type-specific monoclonal antibodies recognize either A or M LPS only. The type C monoclonal antibodies bind epitopes common to both A and M LPS that are not shared with Y. enterocolitica 0:9 LPS. The type C/Y monoclonal antibodies are specific for epitopes which do cross-react with Y. enterocolitica 0:9.
The Western blot patterns of the type A, C, and C/Y epitopes indicate that two distinct populations of molecules are in the purified A LPS preparation. The differences in immunoprecipitation profiles, Limulus lysate gelation assay activity (Tables 2 and 3) , and binding patterns with B. abortus extract (Fig. 2) indicate that the type C/Y monoclonal antibodies recognize molecules possessing the biologically active lipid A portion of the LPS molecule. The restricted binding pattern of the type C/Y monoclonal antibodies in Western blots of the purified LPS preparation may be attributed to a finite O chain length on the complete A LPS molecule selected for by the purification scheme. The epitopes reactive with monoclonal antibody A are distributed throughout the blotted purified LPS preparation. This indicates that the specific A LPS epitope may occur on molecules other than complete LPS. The specific endotoxin activities of monoclonal antibody A immunoprecipitates, however, indicate that the majority of the A epitopes in this preparation are associated with lipid A. The type C monoclonal antibodies bind epitopes in the purified A LPS preparation not precipitated by the A or C/Y monoclonal antibodies and remove all A and C/Y reactivity. The type C epitopes appear to be common to all PS molecules in the preparation.
The specific reactivities of the monoclonal antibodies described here with epitopes of Brucella native hapten and polysaccharide poly B was not determined. These carbohydrates, as mentioned previously, merit investigation. The availability of well-characterized, purified preparations of these antigens, however, is a limiting factor in their study.
The monoclonal antibodies described here provide tools 
